The Procter & Gamble Company revises financial guidance for the full year of fiscal 2024. For the period, the company maintaining guidance range for organic sales growth of 4% to 5%. The company's squarely in the middle of this range fiscal year-to-date.

This outlook assumes continued normalization in underlying market growth rates that company seen over the past few quarters: Markets will be lapping the last waves of cost recovery pricing and volumes slowly begin to recover. The company also expect the market-level changes it faced through third quarter to continue in fourth quarter, though with some directional improvement. On the bottom line, enabled by 15% core EPS growth year-to-date, the company raising its outlook core earnings per share from a range of 8% to 9% to a range of 10% to 11%.

This outlook includes continued strong investments in innovation and brand building to grow markets and extend the superiority of P&G offerings to consumers. The company estimate commodities will be a tailwind of around $900 million after tax based on current spot prices. This is a modest improvement versus the outlook the company provided last quarter, though nearly all of this benefit has been booked in the first three quarters of the year.